Form 4: Insulet Corp Executive Sells Shares in Recent Transaction

An Insulet Corp executive, Eric Benjamin, sold 4,362 shares of common stock at $267.6 per share on December 16, 2024.

Summary

• Eric Benjamin, an EVP at Insulet Corp, sold 4,362 shares of common stock on December 16, 2024.
• The sale price was $267.6 per share.
• Following the transaction, Mr. Benjamin directly owns 18,702 shares of Insulet Corp common stock.
• This includes 130 shares acquired through the Employee Stock Purchase Plan on May 31, 2024.

Sentiment

Score: 5

Explanation: This is a neutral transaction, a routine filing of an executive stock sale. It does not indicate positive or negative sentiment.

Industry Context

This is a routine filing related to an executive's stock transaction and is common for publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Executive stock transactions are a normal part of compensation and portfolio management in publicly traded companies.
• Form 4 filings are standard practice for reporting insider transactions and are required by the SEC.
• The sale of shares by an executive is not unusual and does not necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on investor sentiment, but is unlikely to have a significant effect on the company's operations or long-term prospects.

Key Dates

Keywords

Insulet Corp, stock sale, executive transaction, Form 4, insider trading, Eric Benjamin, PODD